The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
The Cell Cycle: A Review
Abstract
The cell cycle is a complex process that involves numerous regulatory proteins that direct the cell through a specific sequence of events culminating in mitosis and the production of two daughter cells. Central to this process are the cyclin-dependent kinases (cdks), which complex with the cyclin proteins. These proteins regulate the cell's progression through the stages of the cell cycle and are in turn regulated by numerous proteins, including p53, p21, p16, and cdc25. Downstream targets of cyclin-cdk complexes include pRb and E2F. The cell cycle can be altered to the advantage of many viral agents, most notably polyomaviruses, papillomaviruses, and adenoviruses. The cell cycle often is dysregulated in neoplasia due to alterations either in oncogenes that indirectly affect the cell cycle or in tumor suppressor genes or oncogenes that directly impact cell cycle regulation, such as pRb, p53, p16, cyclin D1, or mdm-2. The cell cycle has become an intense subject of research in recent years. This research has led to the development of techniques useful for the determination of the effects of drugs and toxins on the cell cycle. Any drug or toxin with DNA damaging ability would be expected to alter cell cycle progression, and therefore, the cell cycle should be considered in the design of studies using such chemicals. With the appropriate techniques, cell cycle alterations may also be detected in tissue sections. Because of the ubiquitous nature of the cell cycle, it deserves consideration in the design and interpretation of studies in a wide variety of disciplines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Alberts, B., Johnson, A., Lewis, J., Morgan, D., Raff, M., Roberts, K., & Walter, P. (2017) · W.W. Norton eBooks · doi:10.1201/9781315735368 · Cited by 6,365
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Gerdes, J., Schwab, U., Lemke, H., & Stein, H. (1983) · International Journal of Cancer · doi:10.1002/ijc.2910310104 · Cited by 2,788
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Cell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,039
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
PEST sequences and regulation by proteolysis
Rechsteiner, M., & Rogers, S. W. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10031-1 · Cited by 1,640
Hall, P. A., Levison, D. A., Woods, A. L., Yu, C. C. ‐., Kellock, D. B., Watkins, J. A., Barnes, D. M., Gillett, C. E., Camplejohn, R., Dover, R., et al. (1990) · The Journal of Pathology · doi:10.1002/path.1711620403 · Cited by 1,438
A novel cyclin encoded by a bcl1-linked candidate oncogene
Motokura, T., Bloom, T., Kim, H. G., Jüppner., H., Ruderman, J. V., Kronenberg, H. M., & Arnold, A. (1991) · Nature · doi:10.1038/350512a0 · Cited by 1,265
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Distinct Roles for Cyclin-Dependent Kinases in Cell Cycle Control
van den Heuvel, S., & Harlow, E. (1993) · Science · doi:10.1126/science.8266103 · Cited by 1,092
Moore, P. S., & Chang, Y. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321801 · Cited by 1,078
Inhibition of cyclin-dependent kinases by p21.
Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., & Swindell, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.4.387 · Cited by 1,023
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., & Schmidt, E. V. (1994) · Nature · doi:10.1038/369669a0 · Cited by 965
He, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D. O., & Landau, N. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6705-6711.1995 · Cited by 904
Agarwal, M. L., Agarwal, A., Taylor, W. R., & Stark, G. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8493 · Cited by 858
Activation of the MAP kinase pathway by the protein kinase raf
Howe, L. R., Leevers, S. J., Gómez, N., Nakielny, S., Cohen, P., & Marshall, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90361-f · Cited by 801
Potential Role of Human Cytomegalovirus and p53 Interaction in Coronary Restenosis
Speir, E., Modali, R., Huang, E.-S., Leon, M. B., Shawl, F., Finkel, T., & Epstein, S. E. (1994) · Science · doi:10.1126/science.8023160 · Cited by 753
Inactivation of the p34 cdc2 -Cyclin B Complex by the Human WEE1 Tyrosine Kinase
Parker, L. L., & Piwnica-Worms, H. (1992) · Science · doi:10.1126/science.1384126 · Cited by 716
Guan, K. L., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O'Keefe, C. L., Matera, A. G., & Xiong, Y. (1994) · Genes & Development · doi:10.1101/gad.8.24.2939 · Cited by 714
Mueller, P. R., Coleman, T. R., Kumagai, A., & Dunphy, W. G. (1995) · Science · doi:10.1126/science.270.5233.86 · Cited by 695
Cdc25 cell-cycle phosphatase as a target of c-myc
Galaktionov, K., Chen, X., & Beach, D. (1996) · Nature · doi:10.1038/382511a0 · Cited by 690
Hoffmann, I., Clarke, P. R., Marcote, M. J., Karsenti, E., & Draetta, G. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05631.x · Cited by 684
A p53-Dependent Mouse Spindle Checkpoint
Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., & Reid, B. J. (1995) · Science · doi:10.1126/science.7871434 · Cited by 660
Hirai, H., Roussel, M. F., Kato, J.-Y., Ashmun, R. A., & Sherr, C. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2672 · Cited by 646
Chellappan, S., Kraus, V. B., Kroger, B., Munger, K., Howley, P. M., Phelps, W. C., & Nevins, J. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4549 · Cited by 614
Structural basis of cyclin-dependent kinase activation by phosphorylation
Russo, A. A., Jeffrey, P. D., & Pavletich, N. P. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0896-696 · Cited by 598
Interaction between the retinoblastoma protein and the oncoprotein MDM2
Xiao, Z.-X., Chen, J., Levine, A. J., Modjtahedi, N., Xing, J., Sellers, W. R., & Livingston, D. M. (1995) · Nature · doi:10.1038/375694a0 · Cited by 587
Mutations and altered expression of p16INK4 in human cancer.
Okamoto, A., Demetrick, D. J., Spillare, E. A., Hagiwara, K., Hussain, S. P., Bennett, W. P., Forrester, K., Gerwin, B., Serrano, M., & Beach, D. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11045 · Cited by 539
Jowett, J. B., Planelles, V, Poon, B., Shah, N. P., Chen, M. L., & Chen, I. S. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6304-6313.1995 · Cited by 526
Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
Kessis, T. D., Slebos, R. J., Nelson, W. G., Kastan, M. B., Plunkett, B. S., Han, S. M., Lorincz, A. T., Hedrick, L., & Cho, K. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.3988 · Cited by 526
Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle
Kurki, P., Vanderlaan, M., Dolbeare, F., Gray, J., & Tan, E. M. (1986) · Experimental Cell Research · doi:10.1016/0014-4827(86)90520-3 · Cited by 519
Sontag, E., Fedorov, S., Kamibayashi, C., Robbins, D., Cobb, M., & Mumby, M. (1993) · Cell · doi:10.1016/0092-8674(93)90533-v · Cited by 510
Crook, T., Vousden, K. H., & Tidy, J. A. (1991) · Cell · doi:10.1016/0092-8674(91)90529-8 · Cited by 505
CDC25 Phosphatases as Potential Human Oncogenes
Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M., & Beach, D. (1995) · Science · doi:10.1126/science.7667636 · Cited by 504
Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15.
McGowan, C. H., & Russell, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05633.x · Cited by 493
Heald, R., McLoughlin, M., & McKeon, F. (1993) · Cell · doi:10.1016/0092-8674(93)80048-j · Cited by 462
Cdc25A is a novel phosphatase functioning early in the cell cycle.
Jinno, S., Suto, K., Nagata, A., Igarashi, M., Kanaoka, Y., Nojima, H., & Okayama, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06417.x · Cited by 452
Regulation of the human WEE1Hu CDK tyrosine 15-kinase during the cell cycle.
Watanabe, N., Broome, M., & Hunter, T. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07180.x · Cited by 450
Lee, S., Elenbaas, B., Levine, A., & Griffith, J. (1995) · Cell · doi:10.1016/s0092-8674(05)80006-6 · Cited by 405
Deletion of p16 and p15 genes in brain tumors.
Jen, J., Harper, J. W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S. D., Willson, J. K. V., Kinzler, K. W., & Vogelstein, B. (1994) · PubMed · Cited by 404
Lavigueur, A., Maltby, V, Mock, D., Rossant, J., Pawson, T., & Bernstein, A. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.9.3982 · Cited by 394
The retinoblastoma protein pathway and the restriction point
Bartek, J., Bartkova, J., & Lukas, J. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80081-0 · Cited by 390
Re, F., Braaten, D., Franke, E. K., & Luban, J. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6859-6864.1995 · Cited by 375
p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis
Kemp, C. J., Wheldon, T., & Balmain, A. (1994) · Nature Genetics · doi:10.1038/ng0994-66 · Cited by 368
Parry, D., Bates, S., Mann, D. J., & Peters, G. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07026.x · Cited by 354
What is the restriction point?
Zetterberg, A., Larsson, O., & Wiman, K. G. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80067-0 · Cited by 351
Cyclin encoded by KS herpesvirus
Chang, Y., Moore, P. S., Talbot, S. J., Boshoff, C. H., Zarkowska, T., Godden-Kent, D., Paterson, H., Weiss, R. A., & Mittnacht, S. (1996) · Nature · doi:10.1038/382410a0 · Cited by 341
Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases
Wang, Y., & Prives, C. (1995) · Nature · doi:10.1038/376088a0 · Cited by 336
McIlwrath, A. J., Vasey, P. A., Ross, G. M., & Brown, R. E. (1994) · PubMed · Cited by 327
O'Connor, P. M., Jackman, J., Jondle, D., Bhatia, K. G., MAGRATH, I. T., & Kohn, K. W. (1993) · PubMed · Cited by 323
Cyclin-Binding Motifs Are Essential for the Function of p21 CIP1
Chen, J., Saha, P., Kornbluth, S., Dynlacht, B. D., & Dutta, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4673 · Cited by 320
The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.
Finlay, C. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.301 · Cited by 311
Zambetti, G. P., Bargonetti, J., Walker, K., Prives, C., & Levine, A. J. (1992) · Genes & Development · doi:10.1101/gad.6.7.1143 · Cited by 311
Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus
Lyttle, D. J., Fraser, K. M., Fleming, S. B., Mercer, A. A., & Robinson, A. J. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.84-92.1994 · Cited by 303
The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
Bártková, J., Lukáš, J., Guldberg, P., Alsner, J., Kirkin, A. F., Zeuthen, J., & Bártek, J. (1996) · PubMed · Cited by 303
Gerdes, J. (1990) · PubMed · Cited by 300
Evidence for a second cell cycle block at G2/M by p53.
Stewart, N., Hicks, G. G., PARASKEVAS, F., & Mowat, M. R. A. (1995) · PubMed · Cited by 300
Elimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase.
Izumi, T., & Maller, J. L. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.12.1337 · Cited by 298
The molecular basis for cell cycle delays following ionizing radiation: a review
Maity, A., McKenna, W. G., & Muschel, R. J. (1994) · Radiotherapy and Oncology · doi:10.1016/0167-8140(94)90408-1 · Cited by 294
Detection of the Ki‐67 antigen in fixed and wax‐embedded sections with the monoclonal antibody MIB1
McCORMICK, D., CHONG, H., HOBBS, C., DATTA, C., & HALL, P. A. (1993) · Histopathology · doi:10.1111/j.1365-2559.1993.tb00135.x · Cited by 294
Cell cycle regulation of human WEE1.
McGowan, C. H., & Russell, P. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07210.x · Cited by 293
Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls.
Benn, J., & Schneider, R. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11215 · Cited by 288
Herpes simplex virus latency-associated transcript is a stable intron.
Farrell, M. J., Dobson, A. T., & Feldman, L. T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.790 · Cited by 287
Human cdc2 protein kinase is a major cell-cycle regulated tyrosine kinase substrate
Draetta, G., Piwnica-Worms, H., Morrison, D., Druker, B., Roberts, T., & Beach, D. (1988) · Nature · doi:10.1038/336738a0 · Cited by 272
Powell, S. N., DeFrank, J. S., Connell, P., Eogan, M., Preffer, F., Dombkowski, D., Tang, W., & Friend, S. H. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)97825-l · Cited by 268
Clarke, A. R., Gledhill, S., Ml, H., Bird, C. C., & Wyllie, A. (1994) · PubMed · Cited by 267
A pragmatic approach to the analysis of DNA histograms with a definable G1 peak
Watson, J. V., Chambers, S. H., & Smith, P. J. (1987) · Cytometry · doi:10.1002/cyto.990080101 · Cited by 256
Bartz, S. R., Rogel, M. E., & Emerman, M. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2324-2331.1996 · Cited by 251
14-3-3 proteins associate with cdc25 phosphatases.
Conklin, D. S., Galaktionov, K., & Beach, D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7892 · Cited by 246
Resnitzky, D., Hengst, L., & Reed, S. I. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4347 · Cited by 246
Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15.
Sebastian, B., Kakizuka, A., & Hunter, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3521 · Cited by 242
Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation.
Galaktionov, K., Jessus, C., & Beach, D. (1995) · Genes & Development · doi:10.1101/gad.9.9.1046 · Cited by 232
Harvey, M., Vogel, H., Morris, D., Bradley, A., Bernstein, A., & Donehower, L. A. (1995) · Nature Genetics · doi:10.1038/ng0395-305 · Cited by 228
p53-catalyzed annealing of complementary single-stranded nucleic acids.
Oberosler, P., Hloch, P., Ramsperger, U., & Stahl, H. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05893.x · Cited by 224
Russell, K., Wiens, L. W., Demers, G. W., Galloway, D. A., Plon, S. E., & Groudine, M. T. (1995) · PubMed · Cited by 213
Induction of cyclin D1 by simian virus 40 small tumor antigen
Watanabe, G., Howe, A., Lee, R. J., Albanese, C., Shu, I.-W., Karnezis, A. N., Zon, L., Kyriakis, J., Rundell, K., & Pestell, R. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12861 · Cited by 210
van Dierendonck, J. H., Wijsman, J. H., Keijzer, R., van de Velde, C. J., & Cornelisse, C. J. (1991) · PubMed Central · Cited by 206
Vpr-induced cell cycle arrest is conserved among primate lentiviruses
Planelles, V, Jowett, J. B., Li, Q. X., Xie, Y., Hahn, B., & Chen, I. S. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2516-2524.1996 · Cited by 194
Luca, F. C., Shibuya, E. K., Dohrmann, C. E., & Ruderman, J. V. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb05009.x · Cited by 194
Celis, J. E., Madsen, P., Celis, A., Nielsen, H. V., & Gesser, B. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80865-7 · Cited by 193
Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins
Nicholas, J., Cameron, K. R., & Honess, R. W. (1992) · Nature · doi:10.1038/355362a0 · Cited by 191
Cayrol, C., & Flemington, E. K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00635.x · Cited by 187
Two distinct mechanisms for negative regulation of the Wee1 protein kinase.
Tang, Z., Coleman, T. R., & Dunphy, W. G. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06017.x · Cited by 177
Antineoplasic activity of parvoviruses
Rommelaere, J., & Cornelis, J. J. (1991) · Journal of Virological Methods · doi:10.1016/0166-0934(91)90024-t · Cited by 176
Hall, M., Bates, S., & Peters, G. (1995) · PubMed · Cited by 174
Cyclins and Cyclin-Dependent Kinases: Theme and Variations
(1995) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60254-7 · Cited by 172
Demers, G. W., Foster, S. A., Halbert, C. L., & Galloway, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4382 · Cited by 172
Defective G2 checkpoint function in cells from individuals with familial cancer syndromes.
Paules, R. S., Levedakou, E. N., Wilson, S. J., Innes, C. L., Rhodes, N., Tlsty, T. D., Galloway, D. A., Donehower, L. A., Tainsky, M. A., & Kaufmann, W. K. (1995) · PubMed · Cited by 169
p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis.
Guillouf, C., Rosselli, F., Krishnaraju, K., Moustacchi, E., Hoffman‐Liebermann, B., & Liebermann, D. A. (1995) · PubMed · Cited by 168
p53 GENE MUTATIONS AND PHOTOCARCINOGENESIS
Nataraj, A. J., Trent, J. C., & Ananthaswamy, H. N. (1995) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1995.tb05262.x · Cited by 167
Yao, S.-L., Akhtar, A. J., Mckenna, K. A., Bedi, G. C., Sidransky, D., Mabry, M. H., Ravi, R. K., Collector, M. I., Jones, R. J., Sharkis, S. J., et al. (1996) · Nature Medicine · doi:10.1038/nm1096-1140 · Cited by 166
Human cyclin-dependent kinase-activating kinase exists in three distinct complexes.
Drapkin, R., Le Roy, G., Cho, H., Akoulitchev, S., & Reinberg, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6488 · Cited by 166
Bakalkin, G., Selivanova, G., Yakovleva, T., Kiseleva, E., Kashuba, E., Magnusson, K. P., Szekely, L., Klein, G., Terenius, L., & Wiman, K. G. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.3.362 · Cited by 164
Foster, S. A., Demers, G. W., Etscheid, B. G., & Galloway, D. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5698-5705.1994 · Cited by 160
Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer.
Dutta, A., Chandra, R., Leiter, L. M., & Lester, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5386 · Cited by 160
Hwang, E. S., Riese, D. J., Settleman, J., Nilson, L. A., Honig, J., Flynn, S., & DiMaio, D. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3720-3729.1993 · Cited by 158
Physical and Functional Interaction between Wild-Type p53 and mdm2 Proteins
Haines, D. S., Landers, J. E., Engle, L. J., & George, D. L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1171 · Cited by 153
Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21
Pan, Z.-Q., Reardon, J. T., Li, L., Flores-Rozas, H., Legerski, R., Sancar, A., & Hurwitz, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.22008 · Cited by 151
Landers, J. E., Haines, D. S., STRAUSS, J. F., & George, D. L. (1994) · PubMed · Cited by 143
Little, J. B., Nagasawa, H., Keng, P. C., Yu, Y., & Li, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11033 · Cited by 142
Cyclins: wheels within wheels.
Pines, J. (1991) · PubMed · Cited by 140
Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFβ-treated cells
Mal, A. K., Poon, R. Y. C., Howe, P. H., Toyoshima, H., Hunter, T. R., & Harter, M. L. (1996) · Nature · doi:10.1038/380262a0 · Cited by 137
Sequential Dephosphorylation of p34 on Thr-14 and Tyr-15 at the Prophase/Metaphase Transition
Borgne‐Sanchez, A., & Meijer, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27847 · Cited by 137
Jung, J. U., Stäger, M., & Desrosiers, R. C. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7235 · Cited by 137
Demers, G. W., Espling, E., Harry, J. B., Etscheid, B. G., & Galloway, D. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.6862-6869.1996 · Cited by 136
Membrane localization of the kinase which phosphorylates p34cdc2 on threonine 14.
Kornbluth, S. A., Sebastian, B., Hunter, T. R., & Newport, J. W. (1994) · Molecular Biology of the Cell · doi:10.1091/mbc.5.3.273 · Cited by 131
Wang, J., Zindy, F., Chenivesse, X., Lamas, E., Henglein, B., & Bréchot, C. (1992) · PubMed · Cited by 127
Hall, J. A. (1996) · Physiotherapy · doi:10.1016/s0031-9406(05)66904-0 · Cited by 122
Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice.
Bouffler, S. D., Kemp, C. J., Balmain, A., & Cox, R. (1995) · PubMed · Cited by 121
Immunohistochemistry of Cyclin D1 in Human Breast Cancer
Zhang, S.-Y., Caamaño, J., Cooper, F., Guo, X., & Klein–Szanto, A. J. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/102.5.695 · Cited by 120
The D-type cyclins and their role in tumorigenesis
Peters, G. G. (1994) · Journal of Cell Science · doi:10.1242/jcs.1994.supplement_18.13 · Cited by 117
Modulation of microtubule dynamics during the cell cycle
McNally, F. J. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80044-5 · Cited by 116
Aagaard, L., Lukas, J., Bártková, J., Kjerulff, A. A., Strauss, M., & Bártek, J. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610120 · Cited by 115
Washimi, O., Nagatake, M., Osada, H., Ueda, R., Koshikawa, T., Seki, T., Takahashi, T., & Takahashi, T. (1995) · PubMed · Cited by 114
Barbareschi, M., Caffo, O., Doglioni, C., Fina, P., Marchetti, A., Buttitta, F., Leek, R., Morelli, L., Leonardi, E., Bevilacqua, G., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.339 · Cited by 113
Phosphorylation of transcriptional factors and cell-cycle-dependent proteins by casein kinase II
Meisner, H. M., & Czech, M. (1991) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(91)90076-b · Cited by 108
Dephosphorylation of human p34cdc2 kinase on both Thr‐14 and Tyr‐15 by human cdc25B phosphatase
Honda, R., Ohba, Y., Nagata, A., Okayama, H., & Yasuda, H. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80540-b · Cited by 103
Hirst, K. L., Fisher, F. A., McAndrew, P. C., & Goding, C. R. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06876.x · Cited by 102
Doglioni, C., Pelosio, P., Laurino, L., Macrì, E., Meggiolaro, E., Favretti, F., & Barbareschi, M. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199607)179:3<248::aid-path571>3.0.co;2-6 · Cited by 101
Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells.
Kovacs, A., Weber, M. L., Burns, L. J., Jacob, H., & Vercellotti, G. M. (1996) · Europe PMC (PubMed Central) · Cited by 93
Monoclonal antibodies Ki‐S3 and Ki‐S5 yield new data on the ‘Ki‐67’proteins
Heidebrecht, H. J., Buck, F., Haas, K., Wacker, H. H., & Parwaresch, R. M. (1996) · Cell Proliferation · doi:10.1111/j.1365-2184.1996.tb00984.x · Cited by 92
Yasui, W., Akama, Y., Kuniyasu, H., Yokozaki, H., Semba, S., Shimamoto, F., & Tahara, E. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199610)180:2<122::aid-path647>3.0.co;2-c · Cited by 90
Hwang, E.-S., Naeger, L. K., & DiMaio, D. (1996) · PubMed · Cited by 90
Lin, J., & Simmons, D. T. (1991) · Journal of Virology · doi:10.1128/jvi.65.12.6447-6453.1991 · Cited by 89
Es, H., Picksley, S. M., & Kh, V. (1994) · PubMed · Cited by 88
Schang, L. M., Hossain, A., & Jones, C. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3807-3814.1996 · Cited by 87
The proliferation‐associated Ki‐67 protein: definition in molecular terms
Duchrow, M., Gerdes, J., & Schlüter, C. (1994) · Cell Proliferation · doi:10.1111/j.1365-2184.1994.tb01421.x · Cited by 85
Bousset, K., Henriksson, M., Lüscher‐Firzlaff, J., Litchfield, D. W., & Lüscher, B. (1993) · PubMed · Cited by 79
Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas
Nikaido, T., Li, S., Shiozawa, T., & Fujii, S. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960915)78:6<1248::aid-cncr12>3.0.co;2-0 · Cited by 74
Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents.
Eldrige, S. R., Butterworth, B. E., & Goldsworthy, T. L. (1993) · Environmental Health Perspectives · doi:10.1289/ehp.93101s5211 · Cited by 65
Gadbois, D. M., Crissman, H. A., Nastasi, A. J., Habbersett, R., Wang, S.-K., Chen, D. J., & Lehnert, B. E. (1996) · Radiation Research · doi:10.2307/3579303 · Cited by 62
Slebos, R. J. C., Baas, I. O., Clement, M. J., Polak, M. M., Mulder, J., van den Berg, F. M., Hamilton, S., & Offerhaus, G. J. A. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.333 · Cited by 62
The ultrastructure of transmissible murine colonic hyperplasia.
Johnson, E. A., & Barthold, S. W. (1979) · PubMed · Cited by 57
Genetics and cytogenetics of retinoblastoma
Horsthemke, B. (1992) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(92)90055-d · Cited by 56
Arroyo, M., & Raychaudhuri, P. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.22.5947 · Cited by 56
Beeck, A. O. D., Anouja, F., Mousset, S., Rommelaere, J., & Caillet-Fauquet, P. (1995) · PubMed · Cited by 55
Association of p60c-src with polyoma virus middle-T antigen abrogating mitosis-specific activation
Kaech, S., Covic, L., Wyss, A., et al. (1991) · Nature · doi:10.1038/350431a0 · Cited by 52
Ultraviolet radiation induction of squamous cell carcinomas in p53 transgenic mice.
Li, G., Ho, V. C., Berean, K. W., & Tron, V. A. (1995) · PubMed · Cited by 52
Novel p21WAF1/CIP1 mutations in superficial and invasive transitional cell carcinomas.
Malkowicz, S. B., Je, T., Aj, L., Ta, C., Maruta, Y., & Tw, M. (1996) · PubMed · Cited by 50
Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer
Yamamoto, H., Monden, T., Ikeda, K., Izawa, H., Fukuda, K., Fukunaga, M., Tomita, N., Shimano, T., Shiozaki, H., & Monden, M. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.238 · Cited by 48
Why are there so many CDK inhibitors?
Xiong, Y. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00012-1 · Cited by 46
Influence of adeno-associated virus on adherence and growth properties of normal cells
Bantel‐Schaal, U., & Stöhr, M. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.773-779.1992 · Cited by 44
Opgenorth, A., Nation, N., Graham, K., & McFadden, G. (1993) · Virology · doi:10.1006/viro.1993.1092 · Cited by 44
Shi, Y., Zou, M., Farid, N., & Al‐Sedairy, S. T. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.546 · Cited by 44
Valli, V. E., & Parry, B. W. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-391607-5.50010-8 · Cited by 43
TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines
Xu, L. L., Davidson, B. J., Murty, V. V. V. S., Li, R., Sacks, P. G., Garin‐Chesa, P., Schantz, S. P., & Chaganti, R. S. K. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590316 · Cited by 40
Matsushita, K., Kobayashi, S. S., Kato, M., Itoh, Y., Okuyama, K., Sakiyama, S., & Isono, K. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960822)69:4<259::aid-ijc3>3.0.co;2-w · Cited by 31
Distribution of Hypoxia and Proliferation Associated Markers in Spontaneous Canine Tumors
Raleigh, J. A., Zeman, E. M., Calkins, D. P., McEntee, M. C., & Thrall, D. Ε. (1995) · Acta Oncologica · doi:10.3109/02841869509093987 · Cited by 31
Freund, R., Bauer, P. H., Crissman, H. A., Bradbury, E. M., & Benjamin, T. L. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.7227-7234.1994 · Cited by 29
Hass, R., Gunji, H., Hirano, T., Weichselbaum, R. R., & Kufe, D. W. (1993) · PubMed · Cited by 29
Thomas, M., Massimi, P., & Banks, L. (1996) · PubMed · Cited by 27
Growth properties of a human melanoma cell line are altered by adeno‐associated parvovirus type 2
Bantel‐Schaal, U. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600223 · Cited by 24
Aoyagi, M., Yamamoto, M., Wakimoto, H., Azuma, H., Hirakawa, K., & Yamamoto, K. (1995) · Stroke · doi:10.1161/01.str.26.12.2328 · Cited by 23
MONAGHAN, P., Perusinghe, N. P., Nicholson, R. I., McClelland, R. A., O'Hare, M. J., Lane, D. P., Jayatilake, H., & Gusterson, B. A. (1991) · Cell Biology International Reports · doi:10.1016/0309-1651(91)90003-2 · Cited by 20
Metcalf, J. B., Bates, R. C., & Lederman, M. (1990) · Journal of Virology · doi:10.1128/jvi.64.11.5485-5490.1990 · Cited by 17
Barth, H., & Kinzel, V. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041620107 · Cited by 10
(1995) · PubMed
Cited by
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Huang, R.-X., & Zhou, P.-K. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0150-x · Cited by 1,198
Boonstra, J., & Post, J. A. (2004) · Gene · doi:10.1016/j.gene.2004.04.032 · Cited by 737
AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2
Vasudevan, S., & Steitz, J. A. (2007) · Cell · doi:10.1016/j.cell.2007.01.038 · Cited by 656
MADDIKA, S., ANDE, S., PANIGRAHI, S., PARANJOTHY, T., WEGLARCZYK, K., ZUSE, A., ESHRAGHI, M., MANDA, K., WIECHEC, E., & LOS, M. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.01.003 · Cited by 461
Effects of low dose quercetin: Cancer cell‐specific inhibition of cell cycle progression
Jeong, J., An, J. Y., Kwon, Y. T., Rhee, J. G., & Lee, Y. J. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21977 · Cited by 380
Metadata
- Authors
- Schafer, K. A.
- Venue
- Veterinary Pathology
- Publisher
- SAGE Publications
- Published
- 1998-11
- Volume
- 35
- Issue
- 6
- Pages
- 461-478
- ISSN
- 0300-9858 (ISSN-L)
- 1544-2217
- OpenAlex
- W2146428402
- Cited by
- 604
- References
- 164
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.